MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/hem3.70111

Медицинская библиотека · HemaSphere · 2025

Mild or moderate hemophilia is not always a mild or moderate bleeding disorder: Back to the clinical phenotype.

Rodeghiero Francesco, Ghiotto Lisanna, Pontalto Luca, Casini Alessandro, Castaman Giancarlo, Abdul-Kadir Rezan, Berntorp Erik, Bodó Imre, Degenaar-Dujardin Manon, Fijnvandraat Karin, Gresele Paolo, Key Nigel S, Lassila Riitta, Leebeek Frank W G, Lillicrap David, Makris Mike, Meijer Stephan, Mezzano Diego, Noris Patrizia, Pabinger Ingrid, Ragni Margaret V, Silva David, Srivastava Alok, Tosetto Alberto, Windyga Jerzy, Zieger Barbara

СтатьяПеревод в очереди

Аннотация

In a previous paper, a comprehensive clinicopathologic approach to mild and moderate bleeding disorders (MBD) was proposed by an international working group (IWG) as a part of a project promoted by the European Hematology Association (EHA) on the development of guidelines on the various MBDs. A single pre-diagnosis grade 4 bleeding event according to the ISTH-BAT scale or a comparable event after diagnosis was considered sufficient to classify a patient as affected by a severe bleeding disorder (SBD). In this article, the original IWG integrated by experts and patients' representatives proposed by the European Haemophilia Consortium (EHC) and European Association of Haemophilia and Allied Disorders (EAHAD) applied these criteria to mild and moderate hemophilia A and B to establish the proportion of cases that would be reclassified as SBD taking into account bleeding phenotype, thus improving over the current classification based exclusively on basal factor VIII or IX level. To this aim, publications of unselected cases with bleeding history available from birth to the time of publication were considered to estimate the incidence of a first severe bleeding event. More than 20% of cases with mild or moderate hemophilia met the criteria for SBD by experiencing joint or non-joint severe bleeding events. Furthermore, a significant proportion of patients developed an inhibitor against factor VIII or IX. These results, based on a rigorous methodologic approach, substantiate the criticism of the current classification of hemophilia and argue for the adoption of a new classification that takes into account bleeding phenotype in addition to basal clotting activity.

Для цитирования: Rodeghiero Francesco, Ghiotto Lisanna, Pontalto Luca, Casini Alessandro, Castaman Giancarlo, Abdul-Kadir Rezan, Berntorp Erik, Bodó Imre, Degenaar-Dujardin Manon, Fijnvandraat Karin, Gresele Paolo, Key Nigel S, Lassila Riitta, Leebeek Frank W G, Lillicrap David, Makris Mike, Meijer Stephan, Mezzano Diego, Noris Patrizia, Pabinger Ingrid, Ragni Margaret V, Silva David, Srivastava Alok, Tosetto Alberto, Windyga Jerzy, Zieger Barbara. Mild or moderate hemophilia is not always a mild or moderate bleeding disorder: Back to the clinical phenotype.. HemaSphere. 2025. DOI: 10.1002/hem3.70111.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.